Finding effective treatments and, ultimately, a cure for fragile X syndrome, the most common inherited cause of autism.
Mission and History
In 1993, three new parents learned that their first-born sons had fragile X syndrome.
There was no fragile X website or Facebook group then, and just a handful of scientists were studying fragile X. There was no hope. The US government was spending only $30,000 per year to find a cure!
They founded FRAXA Research Foundation in 1994 — a nonprofit, tax-exempt organization based in Newburyport, Mass. Committed to finding a cure for fragile X, FRAXA has funded more than $26 million in biomedical research, yielding discoveries that are changing the lives of families coping with fragile X.
FRAXA is one of the most efficient and effective charities in the world, with management and general expenses under 4 percent and research expenditures at 86 percent. Three Nobel Laureates sit on our volunteer Scientific Advisory Board.
FRAXA Tackles Bottlenecks, Accelerates Progress toward a Cure
Along with funding research, FRAXA runs scientific meetings, advises pharmaceutical companies large and small, and provides education on college campuses, community settings, and international conferences. Families can reach out to FRAXA for resources, guidance, referrals, and an international community of support.
Fragile X research is drastically underfunded, considering its high prevalence, prospects for a cure, and the promise that this research holds for advancing understanding of other disorders like autism, Alzheimer’s disease, and X-linked developmental disabilities.
URL: | https://www.fraxa.org/ |
---|
User Comments/Questions
Add Comment/Question